Recently, genome-wide association studies have implicated the human LIN28B locus in regulating height and the timing of menarche 1-5 . LIN28B and its homolog LIN28A are functionally redundant RNA-binding proteins that block biogenesis of let-7 microRNAs 6-9 . lin-28 and let-7 were discovered in Caenorhabditis elegans as heterochronic regulators of larval and vulval development but have recently been implicated in cancer, stem cell aging and pluripotency 10-13 . The let-7 targets Myc, Kras, Igf2bp1 and Hmga2 are known regulators of mammalian body size and metabolism [14] [15] [16] [17] [18] . To explore the function of the Lin28-Let-7 pathway in vivo, we engineered transgenic mice to express Lin28a and observed in them increased body size, crown-rump length and delayed onset of puberty. Investigation of metabolic and endocrine mechanisms of overgrowth in these transgenic mice revealed increased glucose metabolism and insulin sensitivity. Here we report a mouse that models the human phenotypes associated with genetic variation in the Lin28-Let-7 pathway.
l e t t e r s
Recently, genome-wide association studies have implicated the human LIN28B locus in regulating height and the timing of menarche [1] [2] [3] [4] [5] . LIN28B and its homolog LIN28A are functionally redundant RNA-binding proteins that block biogenesis of let-7 microRNAs 6-9 . lin-28 and let-7 were discovered in Caenorhabditis elegans as heterochronic regulators of larval and vulval development but have recently been implicated in cancer, stem cell aging and pluripotency [10] [11] [12] [13] . The let-7 targets Myc, Kras, Igf2bp1 and Hmga2 are known regulators of mammalian body size and metabolism [14] [15] [16] [17] [18] . To explore the function of the Lin28-Let-7 pathway in vivo, we engineered transgenic mice to express Lin28a and observed in them increased body size, crown-rump length and delayed onset of puberty. Investigation of metabolic and endocrine mechanisms of overgrowth in these transgenic mice revealed increased glucose metabolism and insulin sensitivity. Here we report a mouse that models the human phenotypes associated with genetic variation in the Lin28-Let-7 pathway.
To investigate the function of Lin28a in vivo, we generated a transgenic mouse strain that expressed the M2 reverse tetracycline transactivator (M2-rtTA) from the Gt(ROSA)26Sor (also known as Rosa26) locus and Flag-tagged mouse Lin28a from the Col1a1 (Collagen 1a1) locus (Fig. 1a) 19 . We observed that mice carrying the Lin28a transgene were larger than nontransgenic littermates, even in the absence of the M2-rtTA transgene and/or doxycycline induction. Transgene-bearing animals also had wider facies and coarser hair (Fig. 1b) . Lin28a transgenic animals showed an increased growth rate and in adulthood were heavier and longer (Fig. 1c,d ). Newborn wildtype and Lin28a transgenic pups were the same size ( Supplementary  Fig. 1a ). Differences in weight and crown-rump length became apparent after weaning, and the increased growth of transgenic mice was characterized by a prolonged growth period with higher plateaus for height and weight. In contrast, we found that Lin28a knockout mice (S.R.V., G.S., H.Z., W.S.E., G.C. Heffner et al., unpublished data) weighed 20% less at birth than wild-type pups but did not survive long enough for further analysis (Supplementary Fig. 1b) .
Dual-energy X-ray absorptiometry imaging revealed no change in percentage body fat or lean mass in Lin28a transgenic mice but it did show increased bone mineral content and density (Fig. 1e) . Organ mass was increased in relative proportion to total body weight, suggesting appropriate regulation of organ size relative to overall body growth (Fig. 1f) . To control for any possible effects of doxycycline induction of the engineered Col1a1 locus, we generated a mouse strain using the KH2 embryonic stem cell line without a targeted transgene. After 5 weeks of doxycycline treatment, the wild-type, induced and uninduced mice containing the engineered Col1a1 allele showed no differences in weight (Supplementary Fig. 1c) . Taken together, our data show that Lin28a transgenic mice have increased body size, a phenotype associated with genetic variation in the human LIN28B locus 1 .
Given recent studies associating the LIN28B locus with later age at menarche 2-5 , we investigated the timing of reproductive maturity in these mice. Vaginal opening is a key milestone in sexual development and a reliable marker for the onset of mouse puberty 20 . In Lin28a transgenic mice, we observed a 2.24-and 2.18-d delay in vaginal opening in the CD-1 and C57BL/6 strains, respectively ( Table 1 and Fig. 2a,b; both P < 0.002). Puberty was delayed despite the fact that Lin28a transgenic mice were heavier at the time of vaginal opening in both strain backgrounds ( Table 1 and Fig. 2c ; both P < 0.0001). At 26 d of age, the uterine plus ovarian mass was greater in wild-type mice, indicating delayed sexual development in transgenic mice ( Fig. 2d ; P < 0.002). Wild-type and Lin28a transgenic mice achieved first estrus Lin28a transgenic mice manifest size and puberty phenotypes identified in human genetic association studies l e t t e r s at day 27.3 and day 31.8, respectively ( Fig. 2e ; P = 0.0106). Moreover, mating experiments revealed that Lin28a transgenic animals had a ~3-d delay to date of first litter ( Fig. 2f ; P = 0.0351), correlating well with the delays in vaginal opening and first estrus. We noted that the size of the first litter was markedly larger in the transgenic than in the wild-type animals (16.4 offspring compared to 9.67, P = 0.0002; Fig. 2g ), though overall fertility was no different over the first 3 months of life, indicating that altered timing of sexual maturation was not due to an ability to reproduce.
We then analyzed expression of the Lin28a transgene and the Let-7 family members in various organs. Normally, both Lin28a and Lin28b are highly expressed in early murine embryos until embryonic day (E) 10.5. Thereafter, their patterns diverge: Lin28b is expressed in the fetal liver, blood and brain, whereas Lin28a is expressed in the intestinal crypts, muscle, heart, testes and ovary 21 . Using RT-PCR, we observed that the combined transgene and endogenous Lin28a mRNA expression was increased in multiple organs in the transgenic mice, resulting from ectopic expression of the Lin28a transgene from the Col1a1 locus in both neonates and adults (Fig. 3a,b) . In adults, there was a sevenfold increase in the level of Lin28a mRNA present in the skeletal muscle, a fivefold increase in the level in the ovary and a fourfold increase in the level in the hypothalamus (Fig. 3a) . There was a threefold increase in the presence of Lin28a in the neonatal limb, which contains skin and muscle (Fig. 3b) . These changes were small, considering that endogenous Lin28a is expressed in these tissues. In the muscle, skin and neonatal limb, the additional Lin28a protein functioned to suppress Let-7a and Let-7g processing (Fig. 3c,d) . In contrast, Let-7a and Let-7g levels were preserved in the liver, where Lin28a is absent (Fig. 3c,d ). To corroborate these results, we performed immunohistochemistry and observed increased Lin28a protein in skin and muscle (Fig. 3e) but not in other tissues (Supplementary Fig. 2 ). Within the hypothalamic-pituitary-gonadal axis, endogenous Lin28a is normally only expressed in the pituitary gland and the ovary. Despite overexpression of Lin28a in the hypothalamus and ovary (Fig. 3a) , we found no decrease of Let-7a or Let-7g in the hypothalamic-pituitary-gonadal axis, demonstrating that Lin28a and Let-7 are uncoupled in some tissues (Fig. 3f) .
In a separate study, we showed that doxycycline induction of Lin28a expression expands transit-amplifying cell numbers in a cell-autonomous manner in the intestinal crypts, blood and skin (S.R.V., G.S., H.Z., W.S.E., G.C. Heffner, et al., unpublished data), supporting the hypothesis that increased progenitor cell proliferation leads to both organ and whole-body enlargement. Doxycycline induction in Lin28a transgenic animals led to rapid death associated with marked gut pathology, thus precluding the analysis of growth phenotypes associated with higher levels of Lin28a. The uninduced transgenic mice had thickened skin, larger bones and proportionally enlarged visceral organs. Microscopically, we noted hyperplasia of the skin and bone (Fig. 3g) , but no differences in visceral organ histology ( Supplementary Figs. 2 and 3) . Livers from transgenic mice were 50-60% larger than livers from wild-type littermates ( Fig. 1f) and showed increased cell proliferation, as assayed by KI-67 staining, but we observed no increase in cell size ( Supplementary Fig. 3a-c) . Skeletal muscle cell diameters were also the same in transgenic mice and wild-type littermates ( Supplementary Fig. 3c ). To determine if Lin28a, human LIN28B or Let-7g could cause cell hypertrophy, we induced these genes in three doxycyclineinducible embryonic stem cells and observed that cell size was unaffected ( Supplementary Fig. 3d ). These data show that Lin28a mediates organ overgrowth by increasing cell numbers rather than cell size.
The proportional overgrowth observed here suggested that endocrine or metabolic mechanisms might be governing organismal growth. We did not observe pituitary adenomas, and serum growth hormone and Igf1 levels were not elevated ( Supplementary Fig. 4 ), ruling out these potential etiologies of gigantism. Lin28a has been shown to enhance protein translation of Igf2, and loss of IGF2 imprinting (f) Relative organ weights of transgenic animals (n = 7) normalized to wild-type animals (n = 7). All values represent means ± s.e.m. (*P < 0.05, **P < 0.01), and the numbers of mice (n) are shown in the chart or noted in the legend. 22, 23 . We found a ~20-fold increase of Igf2 mRNA in liver and a twofold increase in muscle (Fig. 4a) . To determine whether Igf2 was driving overgrowth, we crossed Lin28a transgenic females to Igf2 null males and found that Lin28a transgenic mice lacking paternal Igf2 were still overgrown (Supplementary Fig. 5a ).
We confirmed that Igf2-coding mRNA was absent ( Supplementary  Fig. 5b ), ruling out an Igf2-dependent mechanism. Individuals with Beckwith-Wiedemann syndrome also have hypoglycemia, leading us to test whether enhanced glucose utilization was contributing to overgrowth 24 . We first found that fasting and fedstate glucose levels were lower in transgenic mice (Fig. 4b,c) . Using the glucose tolerance test, we showed that both transgenic males and transgenic females cleared glucose more efficiently (Fig. 4d,e) . Using the insulin tolerance test, we found that transgenic mice also had increased insulin sensitivity (Fig. 4f,g ). To show that the lower glucose was due to an increase in peripheral tissue sensitivity rather than an increase in secreted insulin, we measured insulin levels at fasting and at 30 min after a glucose challenge and found that both levels were lower in transgenic mice (Fig. 4h) . Consistent with a chronically decreased need for insulin, islets were smaller in transgenic animals at two ages (Fig. 4i) , further supporting the hypothesis that Lin28a mediates enhanced glucose uptake in peripheral tissues. Notably, the Lin28a transgenic mice lacking paternal Igf2 still showed enhanced glucose uptake and lower fed-state glucose levels ( Supplementary  Fig. 5c,d) , demonstrating that this phenotype is not Igf2 dependent.
Because Lin28a is normally expressed in muscle, a major organ for glucose processing, and because the transgenic mice expressed sevenfold more Lin28a in muscle than wild-type mice, we reasoned that overexpression of Lin28a in muscle might drive increased glucose uptake. We overexpressed Lin28a in C2C12 myoblasts, differentiated them for 1 week, and subsequently found increased 2-deoxy-d-[ 3 H] glucose uptake relative to controls (Fig. 4j) . In contrast, short hairpin RNA (shRNA) knockdown of Lin28a in C2C12 cells led to a reduction in labeled glucose uptake (Fig. 4k) , demonstrating that Lin28a is both necessary and sufficient for enhanced glucose uptake in these cells. To identify mechanisms involved in growth and glucose metabolism, we performed genomewide mRNA expression analysis in 5-week-old skeletal muscle. Using gene-set enrichment analysis 25, 26 , we found that expression signatures associated with Let-7 targets, hypoxia and the Ras pathway were most 
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Let-7 in the adult HPG axis l e t t e r s substantially upregulated, whereas six of the 15 most downregulated sets involved oxidative phosphorylation or mitochondrial genes (Fig. 4l) . We hypothesized that increased glucose uptake, increased activity of hypoxia pathways and decreased oxidative phosphorylation represented an increase in glycolytic metabolism. To test this, we measured serum lactate and found that Lin28a transgenic mice generated more of this glycolytic metabolite than wild-type controls after glucose challenge (Fig. 4m) . Together, these data suggest that overexpression of Lin28a in skeletal muscle alters the metabolic state of the tissue, driving enhanced glucose uptake and favoring glycolytic metabolism. Because the M2 isoform of pyruvate kinase (Pkm2) drives glycolysis in embryos and cancer cells 27, 28 , we investigated whether Lin28a might be activating Pkm2 in vivo. However, no Pkm2 RNA or protein was detected in skeletal muscle or liver of adult wild-type or transgenic animals, excluding Pkm2 expression as a mechanism for increased glycolysis in the Lin28a transgenic mice (data not shown).
Because polymorphisms identified through genome-wide association studies are typically associated with modest changes in gene or cis-regulatory activity, it is difficult to ascertain whether SNPs are associated with gain-of-function or loss-of-function effects. In contrast, knockout or transgenic mice often show either dramatic phenotypes (for example, lethality) or no associated phenotype at all, making it difficult to model human genetic variation. When induced by doxycycline, the Lin28a transgenic mice succumb to gene hyperfunction. In the uninduced state, phenotypes associated with variation at the human LIN28B locus and in the loci of LET-7 target genes were observed due to 'leaky' expression that modestly alters Lin28a and Let-7 levels. Although Lin28a also has Let-7-independent functions, the fact that the LET-7 targets DOTL1, HMGA2 and CDK6 are also associated with taller stature 1, 15, 29 suggests that LIN28B acts through LET-7 to affect height. Murine knockouts of many Let-7 targets such as Hmga2, Igf2bp1 and Myc are runted, suggesting that larger body size could result from reduced Let-7 suppression of its growth-promoting targets [14] [15] [16] [17] [18] . In the mouse model we generated, increased Lin28a in muscle resulted in a modest decrease of Let-7 and a global increase in Let-7 target gene expression (Fig. 4l) . In C. elegans, loss of lin-28 results in precocious vulval differentiation and premature developmental progression 30, 31 , whereas loss of let-7 leads to reiteration of larval stages and delayed differentiation 32 . We show that Lin28a gain of function also leads to a delay in mouse puberty. Although increased body size and prepubescent growth rate are correlated with earlier menarche in humans 33 , the LIN28B alleles associated with later menarche were also associated with taller stature [2] [3] [4] [5] . Our model predicts that hyperfunction of LIN28B in humans contributes to increased height and later menarche and indicates that some heterochronic functions of this pathway are conserved from worm to human.
In heterochronic fashion, Lin28a may also coordinate the rapid growth and metabolism of early embryogenesis and in turn delay the phenotypes associated with adulthood. We found that Lin28a causes increased glucose utilization, a mechanism by which it might drive overgrowth in vivo. LET-7-target oncogenes such as MYC and KRAS also have profound effects on metabolism 34, 35 , as the anabolic demands of embryos or tumors must be met by different types of metabolism. In cancer, this use of 'aerobic glycolysis' is known as the Warburg effect 36 , a phenomenon that is just starting to be explored in embryonic development. The Lin28a transgenic mouse represents an invaluable tool for determining the relationship between metabolism, growth and developmental timing.
MeTHods
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturegenetics/. 
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